Commodity | Reporter | Partner | Trade flow | Indicator | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
3002. Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc | USA | Belgium | Imports | Value (US$) | 825,321,404.00 | 1,045,405,669.00 | 1,068,393,948.00 | 1,072,119,608.00 | 548,106,877.00 | 796,753,473.00 | 2,273,777,610.00 | 4,439,192,631.00 | 7,363,659,896.00 | 5,161,944,123.00 | 8,083,702,996.00 | 4,949,777,431.00 |
Value Growth, YoY (%) | -15.78 | 26.66 | 2.19 | 0.34 | -48.87 | 45.36 | 185.38 | 95.23 | 65.87 | -29.89 | 56.60 | -38.76 |
The value of imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to USA from Belgium totalled $ 4.94 billion in 2023. Sales of commodity group 3002 to USA from Belgium declined by 38% compared to 2022.imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" decreased by $ 3.13 billion (the value of sales of commodity group 3002 to USA from Belgium was equal to $8.08 billion in 2022)
Imports of commodity group 3002 amounted to 21% of total merchandise imports to USA from Belgium (in 2023, total imports to USA from Belgium were $ 23 billion). The share of commodity group 3002 in total imports to USA from Belgium decreased by 8.36 p.p. compared to 2022 (it was 29% in 2022 and cumulative imports to USA from Belgium were equal to $ 27 billion).
Imports of commodity group 3002 accounted for 73% of total imports of group "" to USA from Belgium in 2023 (in 2023, the value of imports of commodity group to USA from Belgium was $6.73 billion). The share of purchases of commodity group 3002 in total imports of commodity group to USA from Belgium went down by 5.9 p.p. compared to 2022 (it was 79% in 2022, and imports of commodity group to USA from Belgium accounted for $10.1 billion).
The share of Belgium in total imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to USA amounted to 6.03 percent (4.94 billion USD) in 2023 of 81 billion USD - the value of total merchandise imports of commodity group 3002 to USA in 2023. The share of Belgium in imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to USA went down by -6.43 p.p. in value compared to 2022 (it was 12.4 percent in 2022, and total imports of commodity group 3002 to USA were equal to 64 billion USD).